Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke models
- PMID: 19002200
- DOI: 10.1038/jcbfm.2008.131
Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke models
Abstract
By isolating for the first time ever a peptide transporter from the blood-brain barrier (BBB) and developing an antisense that selectively _targets the brain-to-blood efflux component, we were able to deliver a therapeutic concentration of the neurotrophic peptide pituitary adenylate cyclase-activating polypeptide (PACAP) 27 to brain in animal models of Alzheimer's and stroke. Efflux pumps at the BBB are major causes of BBB impermeability to peptides. PACAP is neuroprotective in vitro in femtomole amounts, but brain uptake of PACAP27 is limited by an efflux component of peptide transport system-6 (PTS-6). Here, we characterized, isolated, and sequenced this component of PTS-6, identifying it as beta-F1 ATPase, and colocalized it with PACAP27 on BBB endothelial cells. Antisenses _targeting the BBB inhibited PACAP27 efflux, thus increasing brain uptake of PACAP27. Treatment with antisense+PACAP27 improved cognition in a mouse model of Alzheimer's disease and reduced infarct size after cerebral ischemia. This represents the first isolation from BBB tissue of a peptide transporter and shows that inhibition of peptide efflux pumps is a potential strategy for drug delivery to brain.
Similar articles
-
Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier.Exp Neurol. 2005 Jan;191(1):137-44. doi: 10.1016/j.expneurol.2004.09.013. Exp Neurol. 2005. PMID: 15589520
-
Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.Neuroscience. 2009 May 5;160(2):434-51. doi: 10.1016/j.neuroscience.2009.02.028. Epub 2009 Feb 21. Neuroscience. 2009. PMID: 19236905
-
The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia.Neuroscience. 2008 Aug 13;155(2):387-402. doi: 10.1016/j.neuroscience.2008.05.003. Epub 2008 May 8. Neuroscience. 2008. PMID: 18590802
-
Pituitary adenylate cyclase-activating polypeptide: Protective effects in stroke and dementia.Peptides. 2020 Aug;130:170332. doi: 10.1016/j.peptides.2020.170332. Epub 2020 May 21. Peptides. 2020. PMID: 32445876 Review.
-
Delivery of peptides to the brain: emphasis on therapeutic development.Biopolymers. 2008;90(5):589-94. doi: 10.1002/bip.20980. Biopolymers. 2008. PMID: 18335425 Review.
Cited by
-
Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Hippocampal Synaptic Transmission and Plasticity: New Therapeutic Suggestions for Fragile X Syndrome.Front Cell Neurosci. 2019 Nov 27;13:524. doi: 10.3389/fncel.2019.00524. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31827422 Free PMC article. Review.
-
Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service.J Clin Med. 2019 Sep 18;8(9):1488. doi: 10.3390/jcm8091488. J Clin Med. 2019. PMID: 31540472 Free PMC article. Review.
-
Unraveling the ischemic brain transcriptome in a permanent middle cerebral artery occlusion mouse model by DNA microarray analysis.Dis Model Mech. 2012 Mar;5(2):270-83. doi: 10.1242/dmm.008276. Epub 2011 Oct 20. Dis Model Mech. 2012. PMID: 22015461 Free PMC article.
-
Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice.Peptides. 2017 Sep;95:25-32. doi: 10.1016/j.peptides.2017.07.007. Epub 2017 Jul 15. Peptides. 2017. PMID: 28720396 Free PMC article.
-
PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.J Mol Neurosci. 2013 Jul;50(3):600-7. doi: 10.1007/s12031-013-0015-7. Epub 2013 Apr 28. J Mol Neurosci. 2013. PMID: 23625270 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical